Premium
After witnessing some of its best years during the COVID-19 pandemic, India’s diagnostics companies landed in a soup during the financial year-ended 2023. As the country’s concerned populace was prompted to take tests during the ranging pandemic through FY21-22, these companies witnessed record high revenues in those years, only to have ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
